Meningococcal Vaccines Market Size, Share & Trends Analysis, Type (Quadrivalent, Bivalent, Other), Age Group (Infants), Children And Adults), Serotype (Serotype A, Serotype B, Others), Brand (Nimenrix, Trumenba, Others), Sales (Channel, Private1, Public), Region and Forecast Period 2022 – 2030

Report ID - MRC_1221 | Pages - 280 | Category - Petrochemicals

Market Insights:

The Meningococcal Vaccines Market was valued at USD 3.11 Bn in 2021, at CAGR of 7.28% during the forecast period (2022-2030), and the Market is projected to be worth USD 5.85 Bn by 2030.

Driver:
The increased adoption of Meningococcal Vaccines in the Petrochemicals industry is due to high workability, Stability of structure, good quality, and Demand for making things better. The demand for Meningococcal Vaccines also has other significant aspects, such as analysis, purchasing volume, costs, pricing analysis, and regulatory framework. Additionally, the increased demand of Meningococcal Vaccines in many sectors also boosts the market growth during the forecast period.

How much is the Meningococcal Vaccines Market worth ?

img

Get Free Sample PDF

The goal of meningococcal immunizations is to guard against Neisseria meningitidis infection. There are vaccines available that specifically target the meningococcus strains A, B, C, W-135 and Y. The vaccinations typically achieve immunity levels of 80% to 100% for two years, with some requiring further booster doses. The vaccines may be multivalent in nature or monovalent, targeted at a particular meningococcus strain. The main driving forces behind the worldwide market for meningococcal vaccinations are the Rising public awareness, a rise in the use of travel vaccines, and more research and development is being done on vaccine technology.

Meningococcal Vaccines Market Research Report” was just released by Market Research Community. It is divided into several categories, including Type (Quadrivalent, Bivalent, Other), Age Group (Infants (0 to 2 years), Children And Adults (2 years & above), Serotype (Serotype A, Serotype B, Serotype C, Serotype W-135, Serotype Y), Brand (Nimenrix, Trumenba, Menactra, Menveo, Bexsero, Others), Sales (Channel, Private1, Public), and companies (Incepta Pharmaceuticals Ltd, BIO-MED, Walvax Biotechnology Co. Ltd, Bio-Manguinhos, Pfizer Inc, Novartis AG, Sanofi S.A., Serum Institute of India Pvt. Ltd, GlaxoSmithKline plc, Merck & Co.Inc), According to the analysis of Market Research Community, The market is projected to grow at a significant pace reaching a CAGR of approximately 7.28%, over the forecast period of 2022–2030.

Report Coverage:

Report AttributesReport Details
Study Timeline2018-2030
Market Size in 2030 (USD Billion)5.85 Billion
CAGR (2022-2030)7.28%
By TypeQuadrivalent, Bivalent, Other
By SerotypeSerotype A, Serotype B, Serotype C, Serotype W-135, Serotype Y
By SalesChannel, Private1, Public
By GeographyNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa
Key PlayersIncepta Pharmaceuticals Ltd, BIO-MED, Walvax Biotechnology Co. Ltd, Bio-Manguinhos, Pfizer Inc, Novartis AG, Sanofi S.A., Serum Institute of India Pvt. Ltd, GlaxoSmithKline plc, Merck & Co.Inc.

Get Free Sample PDF

 Covid-19 Impact:

The COVID-19 pandemic has had a substantial negative influence on the Meningococcal Vaccines market in many different regions of the world. The factors such as limited availability of raw materials, transportation restrictions, the shutdown of manufacturing facilities, and economic slowdown are the major impacts of COVID-19 which hampered the market growth. Shipments were impacted during the initial lockdown due to halted automotive productions and stringent government rules. The overall impact of COVID-19 on the industry is estimated to be minimal because the situation has stabilised. Post covid-19, there was a positive impact on the market growth due to the increased industrial manufacturing processes and rising demand for environment-friendly alternatives.

Industry Competitive Landscape:

The research includes comprehensive profiles of the key players in the market and an analysis of the competitive landscape. The market for sample preparation has grown more quickly as a result of the spike in research and development (R&D), product innovation, different business strategies, and application releases. Key players in the market include-

  • Incepta Pharmaceuticals Ltd
  • BIO-MED
  • Walvax Biotechnology Co. Ltd
  • Bio-Manguinhos
  • Pfizer Inc
  • Novartis AG
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd
  • GlaxoSmithKline plc
  • Merck & Co.Inc

Market Segment Analysis:

Type

  • Quadrivalent
  • Bivalent
  • Other

Age Group

  • Infants (0 to 2 years)
  • Children And Adults (2 years & above)

Serotype

  • Serotype A
  • Serotype B
  • Serotype C
  • Serotype W-135
  • Serotype Y

Brand

  • Nimenrix
  • Trumenba
  • Menactra
  • Menveo
  • Bexsero
  • Others

Sales Channel

  • Private1
  • Public

Region

The regional segment includes Asia Pacific, Europe, North America, the Middle East, and Africa, Latin America. In 2021, some of these regions expected to contribute the largest share during the forecast period.

The factors such as the large and easy availability of basic things, rising purchasing power among the population, and favorable government policies and industrial facilities are estimated to accelerate the industry growth in the region. The growing rate of industrialization is anticipated to boost the presence of Meningococcal Vaccines industries in the region.

Key Meningococcal Vaccines Market Trends

– Based on type, sub-type, technology utilised, applications, end-users, and geographies, the research identifies, defines, and predicts the Global Meningococcal Vaccines Market segments.

– Largest Market Share Held by Industry to Industry for Meningococcal Vaccines

– Based on their expected growth, development patterns and prospects for the future, and contributions to the overall market, it analyses the micro markets.

– Demand from the geographical area is estimated to boost growth.

– Growing Market Segment Adoption in the Meningococcal Vaccines Industry

– Over the forecast period, higher growth rates are anticipated in in some regions

Why Purchase the Industry Report by MRC

There is a huge amount of information in the report, including market trends and business opportunities for the forecast period.

Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) statistics.

Data at the regional, sub-regional, and national levels also includes information on the market’s supply and demand dynamics.

The competitive landscape includes the proportions of important players, recent innovations, and strategy.

Comprehensive product offerings, important financial data, latest advancements, SWOT analysis, and key player tactics.

Table of Content

Table of Content

1. Meningococcal Vaccines Market Introduction

1.1.Market Introduction
1.2.Market Research Methodology
1.2.1.Research Process
1.2.2.Primary Research
1.2.3.Secondary Research
1.2.4.Data Collection Technique
1.2.5.Data Sources
1.3.Market Estimation Methodology
1.3.1.Limitations of the Study
1.4.Product Picture of Meningococcal Vaccines
1.5.Years Considered for the Study
1.6.Research Methodology in brief
1.7.Parent Market Overview
1.8.Overall Global Meningococcal Vaccines Market Regional Demand
1.9.Data Source
1.9.1. Secondary Sources
1.9.2. Primary Sources

2. Meningococcal Vaccines Executive Summary

2.1.Business Trends
2.2.Regional Trends

3.Meningococcal Vaccines Market Dynamics

3.1.Drivers
3.1.1.Drivers
3.2.Restraints
3.2.1.Restraints
3.3.Opportunity
3.4.Impact forces during the forecast years
3.5.Industry Value Chain
3.5.1.Upstream analysis
3.5.2.Downstream analysis
3.5.3.Marketing and Distribution Channel
3.5.3.1.Direct Channel
3.5.3.2.Indirect Channel
3.6.Potential Customers
3.7.Manufacturing Cost Analysis
3.8.Pricing Analysis by Region
3.9.Key Technology Landscape
3.10.Regulatory Analysis
3.11. Porter’s Analysis
3.11.1.Supplier Power
3.11.2.Buyer Power
3.11.3.Substitution Threat
3.11.4.Threat from New Entry
3.11.5.Competitive Rivalry
3.12. PESTEL Analysis
3.12.1.Political Factors
3.12.2.Economic Factor
3.12.3.Social Factors
3.12.4.Technological Factor
3.12.5.Environmental Factors
3.12.6.Legal Factor

4. Global Meningococcal Vaccines Market Segmentation, by Revenue (USD Mn), (2022-2030)

4.1.By Type
4.2.By Application

5.Global Meningococcal Vaccines Market Overview, By Region
5.1. North America Global Meningococcal Vaccines Market Revenue (USD Mn), by Countries, (2022-2030)
5.1.1.US
5.1.2.Canada
5.1.3.Mexico
5.2.Europe Global Meningococcal Vaccines Market Revenue (USD Mn), by Countries, (2022-2030)
5.2.1.Germany
5.2.2.France
5.2.3.UK
5.2.4.Spain
5.2.5.Russia
5.2.6.Italy
5.2.7.BENELUX
5.3.Asia Pacific Global Meningococcal Vaccines Market Revenue (USD Mn), by Countries, (2022-2030)
5.3.1.China
5.3.2. Japan
5.3.3. Australia
5.3.4. South Korea
5.3.5. India
5.3.6. ASEAN
5.4.Latin America Global Meningococcal Vaccines Market Revenue (USD Mn), by Countries, (2022-2030)
5.4.1.Brazil
5.4.2. Argentina
5.4.3. Chile
5.5.Middle East and Africa Global Meningococcal Vaccines Market Revenue (USD Mn), by Countries, (2022-2030)
5.5.1.GCC
5.5.2.Turkey
5.5.3.South Africa

6.Competitive Analysis
6.1.Business Overview
6.2.Business Financials (USD Mn)
6.3.Product Category, Type, and Specification
6.4.Main Business/Business Overview
6.5.Geographical Analysis
6.6.Recent Development
6.7.Swot Analysis

7.Conclusion

8.Disclaimer

To check our Detail TOC, please mail us at: [email protected]

Research Methodology

The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.

Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.

Meningococcal Vaccines Market Size, Share & Trends Analysis, Type (Quadrivalent, Bivalent, Other), Age Group (Infants), Children And Adults), Serotype (Serotype A, Serotype B, Others), Brand (Nimenrix, Trumenba, Others), Sales (Channel, Private1, Public), Region and Forecast Period 2022 – 2030
Back to top button